Playback speed
10 seconds
Barostim and the Window of Opportunity in Class II/III HFrEF Patients THT 2024 Discussion
84 views
April 24, 2024
Hear discussion and insights from Drs. J. Thomas Heywood, JoAnn Lindenfeld, Gurusher Panjrath, and Dmitry Yaranov following the THT 2024 symposium.
Comments 0
Login to view comments.
Click here to Login